Before You Book That In-Vitro Assay: Making Sense of a ‘Typically ≥99%’ HPLC Figure

A supplier page, a quotation email or a product datasheet says the compound is typically ≥99% pure by HPLC. For a laboratory researcher, that line can feel like the green light to schedule bench time, reserve instrument slots and write the material into a protocol. It is not. The phrase summarises what a supplier has observed across batches — useful context, but no substitute for the documentation attached to the vial that will actually sit on your bench. Booking an in-vitro assay before confirming a handful of details is an expensive way to discover that a certificate, a storage condition or a handling step was not what you assumed. The checks below are worth completing first, whether this is a first order or a repeat purchase from a catalogue you think you already know.

What ‘Typically ≥99%’ Actually Describes — and What It Leaves Open

Purity figures published at catalogue level describe a population, not a vial. Research Sciences, for example, states in its FAQs that peptides are typically supplied at ≥99% purity (HPLC tested) and that the exact purity is stated on the Certificate of Analysis (CoA). The homepage separately carries published marketing lines including “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity”. Those are the shop’s current published claims rather than independently audited numbers, and they should be reconfirmed on the live site and, more importantly, against the batch CoA that accompanies your specific order. There is no need to reconcile the headline figures yourself; the batch document governs the material in your hands.

A range across batches, not a promise for your vial

The word “typically” is doing real work in that sentence. It signals a central tendency across a supplier’s history, which may span several production lots, more than one synthesis run, different fill dates and different analytical sessions. A chromatographic purity result is also conditional on the method used to generate it: column chemistry, gradient, detection and integration choices all influence the percentage reported. Two laboratories can both truthfully describe a compound as ≥99% by HPLC and still arrive at different numbers. Before an assay is booked, it is worth establishing which of those descriptions applies to the batch you are about to receive.

Questions worth putting in writing

Ask for the batch-specific figure rather than the catalogue figure, and ask what the chromatogram shows beyond the headline percentage — in particular whether the CoA reports identity as well as purity. The FAQs state that every compound includes a CoA (HPLC) covering purity and identity, which is the minimum needed to make an informed decision. When comparing suppliers, compare their documents rather than their banners; a modestly worded CoA with an identity result and a clear sample reference is more useful than an emphatic headline with nothing behind it.

The Documentation to Open Before You Commit Bench Time

Paperwork is where most pre-assay assumptions are either confirmed or quietly corrected. The FAQs describe a CoA for every product, with compounds manufactured by international partners using solid-phase peptide synthesis (SPPS), independently tested by HPLC and subject to final verification and quality checks in the UK before release. The About page describes a fuller testing framework — purity and identity alongside heavy metals and endotoxin evaluation of submitted samples — presented as a later milestone. The homepage lists “CoAs Janoshik Analytical Reports”. Each of these is a stated position rather than a guarantee about any given vial, so open the document that arrives with your batch and check it matches the material you have.

Read the CoA against the label reference

Vial labels use a reference combining the SKU code and expiry date — the format shown on the site is BPC10-03/27 — and that reference links to the corresponding CoA. Quote it in any correspondence about documentation; it is far more useful than a screenshot of an order confirmation. Older pages and posts on the site still use the names Imperial Sciences UK or Imperial Peptides UK, and the FAQs describe Research Sciences as the parent company with Imperial Peptides UK continuing as a brand. If a document or label uses a name you do not immediately recognise, ask the shop to confirm rather than assuming. Equally, cap colours and other packaging features vary between deliveries and are not indicators of identity, analytical quality or manufacturing origin; the documents and the reference code are.

What an internal test reference does not prove

The FAQs note that restocked products may carry the same Internal Test Reference (ITR) as earlier stock, and that an ITR links to associated sample testing reports. It does not confirm that separate deliveries come from the same production lot or have undergone separate independent testing. If your assay depends on continuity between an earlier batch and a new one — and many do — that distinction matters, and it is worth raising before rather than after you have thawed anything.

When assembling a study, it also helps to work from a listing you can trace end to end: researchers who Buy peptides from the all-products category should move from the listing to the individual product page and then to the batch CoA, rather than relying on the category description alone. All items remain research-use-only materials and are not for human or veterinary use.

Handling, Storage and Assay-Fit Checks That Come After Purity

A ≥99% figure tells you nothing about whether the material suits your particular in-vitro model, and very little about what has happened to it since testing. The FAQ quick guide sets out the handling expectations: allow vials to reach room temperature before opening; work in a clean environment; remove only the amount required for the experiment; store lyophilised peptides at –20°C or below, sealed with desiccant and protected from moisture, heat and light; and avoid repeated freeze–thaw cycles. Reconstituted peptide is less stable and should be held at 2–8°C for short-term laboratory use. The MT-1 listing, as an example of how listings are written, describes a lyophilised research peptide stored at −20°C protected from moisture and light, and at 2–8°C after reconstitution, with reconstitution solutions supplied separately.

Reconstitution is a laboratory calculation, not a routine

For an in-vitro workflow, reconstitution means selecting a diluent volume that yields a working concentration appropriate to your plate or cuvette format, then recording it in the run sheet. Some vials contain trace amounts of mannitol as an excipient — described in the FAQs as aiding stability during lyophilisation, solubility and protection in storage — which is worth knowing when calculating concentrations. A free reconstitution calculator is offered on product pages and in the FAQs, covering mg, mcg, mL and U-100/U-50 scales with optional IU conversions where a factor is known; it is intended for laboratory research use only and must never be used for human or veterinary dosing.

Single compounds, controlled design, clear responsibility

The shop states that it does not supply blended peptides and recommends buying compounds individually and combining them only within a controlled experimental design. If a planned assay depends on a combination, that is a design decision to document rather than a specification to expect from a vial. Materials are not for human or veterinary use, and the purchaser is responsible for lawful use, safe handling, storage and disposal, including compliance with COSHH and laboratory safety standards. Confirm current published wording on dispatch, tracking and documentation at the point of ordering, since site text can change between reading and purchase — and keep the batch CoA with your laboratory records so that the purity figure you planned around is the one you can actually evidence.